If the role of ABL1 point mutations is well-recognized in Chronic Myeloid Leukemia (CML), in ALL the prognostic relevance of detecting small clones of T315I-mutated cells at diagnosis remains to be fully elucidated [64]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.